---
schema_version: "secwatch.filing_event.v1"
accession: "0001703057-26-000031"
form_type: "8-K"
ticker: "ABCL"
cik: "0001703057"
company_name: "AbCellera Biologics Inc."
filed_at: "2026-06-05T16:03:46+00:00"
generated_at: "2026-06-05T16:05:11.600376+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# AbCellera appoints Dr. Victor Sandor as independent director to board

## Summary
- Appointed Victor Sandor, M.D.C.M., to Board as independent director effective June 1, 2026.
- Dr. Sandor brings oncology drug development expertise; previously CMO at Array BioPharma.
- He secured approval of Braftovi and Mektovi at Array and contributed to Jakafi and Faslodex development.
- Sandor currently serves on boards of ADC Therapeutics, Kymera Therapeutics, and Prelude Therapeutics.
- Will not serve on any board committees initially; compensated per non-employee director policy.

## SEC filing metadata
- accession: 0001703057-26-000031
- form_type: 8-K
- ticker: ABCL
- cik: 0001703057
- company_name: AbCellera Biologics Inc.
- filed_at: 2026-06-05T16:03:46+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1703057/000170305726000031/0001703057-26-000031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1703057/000170305726000031/abcl-20260601.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001703057-26-000031
- JSON: https://secwatch.observer/filing/0001703057-26-000031.json
- Plain text: https://secwatch.observer/filing/0001703057-26-000031.txt

## Key facts
- Executive change
  Victor Sandor was appointed as Director at AbCellera Biologics Inc..
  - Action: appointed
  - Role: Director
  source text: On June 1, 2026, the Board of Directors (the "Board") of AbCellera Biologics Inc. (the "Company") appointed Victor Sandor as a new director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1703057/000170305726000031/0001703057-26-000031-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.